Physicians Hall Front

Convalescent Plasma Donations to be Collected by Versiti Blood Centers to Treat COVID-19 Patients

As coronavirus cases continue to rise across the country and the world, Versiti, Inc., a national leader in blood health innovation, will begin collecting plasma from recovered COVID-19 patients to help treat others severely affected with the virus. This blood related treatment could offer hope to hundreds of patients who continue to be diagnosed.

Versiti blood centers is among the first in the U.S. to begin the collection of convalescent plasma. They are working with their partner hospitals to identify patients who have successfully recovered from COVID-19.

“The potential donors must first be proven to have had a COVID-19 diagnosis through a positive lab test result, and must then have a negative test result 14 days after recovering from symptoms,” said Versiti Senior Medical Director Dan A. Waxman, MD. “It’s a very collaborative effort with our hospital partners who will be working to identify and verify the donors.”

Versiti hopes to implement the coronavirus plasma collection program in early April. The donated plasma will be provided directly to the patients of hospitals with whom Versiti is partnering.

The plasma treatment would transfer the antibodies of a recovered patient, into critically ill patients who are currently receiving care.

The plasma donations, which take 30-40 minutes, will be collected at Versiti donor centers in Illinois, Indiana, Michigan, Ohio and Wisconsin.

Though blood group AB is the universal plasma donor, any blood type donor who has recovered from the virus is eligible to donate as part of the program.

MCW Media Contacts

The media relations team at MCW is happy to assist in coordinating experts for interviews. Please reach out to us at:

media@mcw.edu
(414) 955-4725
Contact us

Contact Location Lab Photo